TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Belach Bioteknik AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
665
|
2,858
|
1,386 |
Financial expenses |
3
![]() |
3
|
1 |
Earnings before taxes |
-178
|
510
|
4 |
EBITDA |
-166
|
522
|
16 |
Total assets |
1,030
|
1,278
|
1,885 |
Current assets |
789
|
1,234
|
1,883 |
Current liabilities |
147
|
215
|
1,243 |
Equity capital |
854
|
1,004
|
642 |
- share capital |
45
![]() |
45
|
49 |
Employees (average) |
5
![]() |
5
|
6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
82.9%
|
78.6%
|
34.1% |
Turnover per employee |
133
|
572
|
231 |
Profit as a percentage of turnover |
-26.8%
|
17.8%
|
0.3% |
Return on assets (ROA) |
-17.0%
|
40.1%
|
0.3% |
Current ratio |
536.7%
|
574.0%
|
151.5% |
Return on equity (ROE) |
-20.8%
|
50.8%
|
0.6% |
Change turnover |
-2,202
|
1,585
|
-262 |
Change turnover % |
-77%
|
124%
|
-16% |
Chg. No. of employees |
0
|
-1
|
0 |
Chg. No. of employees % |
0%
|
-17%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.